Irccs Istituto Europeo Di Oncologia (IEO); Oncologia Medica

Milan, Lombardy 20141

0 studies enrolling now · 4 studies all time

What they study most

Advanced BRAFV600 Wild-type Melanoma, Colorectal Cancer, Fallopian Tube Cancer, Gastric Cancer, Ovarian Cancer, Peritoneal Neoplasms

Studies at this site

• A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma — Stopped early
• A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer — Completed
• A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer — Completed